Estimating and examining the costs of inpatient diabetes care in an Irish Public Hospital.
| Publication Type | Academic Article |
| Authors | Friel K, Gillespie P, Coates V, McCauley C, McCann M, O'Kane M, McGuigan K, Khamis A, Manktelow M |
| Journal | Diabet Med |
| Volume | 39 |
| Issue | 4 |
| Pagination | e14753 |
| Date Published | 12/04/2021 |
| ISSN | 1464-5491 |
| Keywords | Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 |
| Abstract | AIM: To estimate and examine hospitalisation costs of Type 1 and Type 2 diabetes in an Irish public hospital. METHODS: A retrospective audit of hospital inpatient admissions over a 5-year period was undertaken, and a wide range of admission-related data were collected for a sample of 7,548 admissions. Hospitalisations were costed using the diagnosis-related group methodology. A series of descriptive, univariate and multivariate regression analyses were undertaken. RESULTS: The mean hospitalisation cost for Type 1 diabetes was €4,027 and for Type 2 diabetes was €5,026 per admission. Sex, admission type and length of stay were significantly associated with hospitalisation costs for admissions with a primary diagnosis of Type 1 diabetes. Age, admission type, diagnosis status, complications status, discharge destination, length of stay and year were significantly associated with hospitalisation costs for admissions with a primary diagnosis of Type 2 diabetes. Length of stay was associated with higher mean costs, with each additional day increasing Type 1 diabetes costs by €260 (p = 0.001) and Type 2 diabetes by €216 (p < 0.001). Unscheduled admissions were associated with significantly lower costs than elective admissions; €1,578 (p = 0.035) lower for Type 1 diabetes and €2,108 (p < 0.001) lower for Type 2 diabetes. CONCLUSIONS: This study presents estimates of the costs of diabetes care in the Irish public hospital system and identifies the factors which influence costs for Type 1 and Type 2 diabetes. These findings may be of interest to patients, the public, researchers and those with influence over diabetes policy and practice in Ireland and internationally. |
| DOI | 10.1111/dme.14753 |
| PubMed ID | 34839536 |
| PubMed Central ID | PMC9299992 |